RSS Feed For (NASDAQ:ALTH)

ALLOS THERAPEUTICS (NASDAQ:ALTH)

6.16 -0 (-0%)
ALLOS THERAPEUTICS (NASDAQ:ALTH) Delayed :
Previous Close $6.16    52 Week High $9.30 
Open $6.23    52 Week Low $4.68 
Day High $6.34    P/E N/A 
Day Low $6.06    EPS $-0.78 
Volume 1,013,249       
More ALTH Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
HIG 3 KFT 3
C 3 PARD 3
NETL 3 ANH 3
AIG 3 HIG 2
STEC 2 KFT 2
AAPL 2 ADM 2
View All Friends, Peers and Foes

StreetInsider Reports on ALTH by Category

Comments on recent ALTH articles

ANDREW OLIVER SATCHELL
on Nov 13, 2009
at 03:55 PM
ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
MARGARET TOWNSEND
on Sep 25, 2009
at 10:33 AM
PRICE CHANGE ARE DAY TRADERS AFTER THIS STOCK?
Article: Shares of Allos Therapeutics (ALTH) Give Back After Strong Opening
Wayne
on Sep 1, 2009
at 07:58 PM
Allos It looks good to me on approval....calls on this stock are looking 10 and 12.50.....if approved opens the drug up to alot more trials and hopefully a success in the fight against cancer
Article: Citi Maintains a 'Buy' on Allos Therapeutics (ALTH), Impressive Durability of Response Shown for PDX in PTCL
Terry Capron
on Dec 8, 2008
at 02:24 PM
Genworth There is news driving the price change. State ins. regulators meeting in Tx. have agreed to lower Capital funding requirements. Do your homework before posting info.
Article: Unusual 11 Mid-Day Movers 12/08: GNW, DRYS, PLD, TBSI Higher; ALTH, LSI, CBST, HL Lower
Dan Gillespie
on Feb 20, 2008
at 03:42 PM
INSM A $3.00 dollar stock trading below a $1.00.
Article: Analyst Call of the Year: Collins Stewart on Encysive (ENCY)

Comments on ALTH


No comments are currently available.